Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Deferred Taxes (2016 - 2019)

Assembly Biosciences has reported Deferred Taxes over the past 4 years, most recently at -$741000.0 for Q4 2019.

  • Quarterly results put Deferred Taxes at -$741000.0 for Q4 2019, down 165.06% from a year ago — trailing twelve months through Sep 2020 was -$741000.0 (down 167.0% YoY), and the annual figure for FY2021 was -$2.5 million, changed.
  • Deferred Taxes for Q4 2019 was -$741000.0 at Assembly Biosciences, down from -$15000.0 in the prior quarter.
  • Over the last five years, Deferred Taxes for ASMB hit a ceiling of $1.1 million in Q4 2018 and a floor of -$9.0 million in Q4 2017.
  • Median Deferred Taxes over the past 4 years was -$24500.0 (2018), compared with a mean of -$932348.7.
  • Biggest five-year swings in Deferred Taxes: tumbled 1355.43% in 2017 and later skyrocketed 112.66% in 2018.
  • Assembly Biosciences' Deferred Taxes stood at -$618000.0 in 2016, then tumbled by 1355.43% to -$9.0 million in 2017, then skyrocketed by 112.66% to $1.1 million in 2018, then tumbled by 165.06% to -$741000.0 in 2019.
  • The last three reported values for Deferred Taxes were -$741000.0 (Q4 2019), -$15000.0 (Q3 2019), and -$11000.0 (Q2 2019) per Business Quant data.